v3.22.2.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 137,638 $ 6,641
Accounts receivable, net 170,380 211,222
Other current assets and prepaids 5,682 107,289
Total Current Assets 313,700 325,152
Other assets 3,131,545
Total Assets 313,700 3,456,697
Current Liabilities:    
Accounts payable 30,206 10,833
Related party payables 172,567 141,592
Accrued expenses 352,176 233,688
Accrued interest payable 74,270 99,445
Convertible notes payable, net 980,290 634,290
Settlement Payable 195,250 195,250
Line of credit – related party 483,677 483,677
Notes Payable 3,174,977 3,174,977
Total Current Liabilities 5,463,413 4,973,752
Total Liabilities 5,463,413 4,973,752
Shareholders’ Deficit    
Common stock, $0.001 par value; 100,000,000,000 shares authorized, at December 31, 2021 and December 31, 2020 there were 172,478,025 and 3,616,044 issued and outstanding, respectively 172,478 3,616
Additional Paid-In-Capital 7,536,452 5,285,449
Accumulated Deficit (12,858,643) (6,806,120)
Total Shareholders’ Deficit (5,149,713) (1,517,055)
Total Liabilities and Shareholders’ Deficit $ 313,700 $ 3,456,697